📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
MOREPEN LABORATORIES LTD.MOREPENLABPharmaceuticals
Open
40.22
High
40.95
Low
39.26
Close
40.26
Volume
2799739
Exchange
nse
Time
12-Mar-2026

Outlook

Score:

5.25

Rating:

FAIR

Candlestick Pattern

CandlepatternofMorepenLaboratoriesis
High Wave
EstimatedStoplossofMorepenLaboratoriesis
39.26
MorepenLaboratorieshasa
Bullishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofMorepenLaboratoriesis
Unpredictableℹ
.

Trend

MorepenLaboratoriesisin
Sideways trendℹ
.
PriceofMorepenLaboratoriesis
Upℹ
by

1.59

%.
Target
Buy@

34.25

Sell@

44.79

Current@

40.26

Volume

ThetradevolumesofMorepenLaboratorieshavebecome
Deficientℹ
ThoughthevolumetrendforMorepenLaboratoriesappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofMorepenLaboratoriesis

Down

by

51.54

%

Valuation

ThecurrentmarketpriceofMorepenLaboratoriesis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth1778crandtotalassetsworth1778cr,thebalancesheetofMorepenLaboratoriesis:
Balancedℹ
.
Cashflow
MorepenLaboratorieshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 10cr

.Itis
Upℹ
by

350

%.
4.91% i.e. ₹ 32cr earned in operatingℹ
49.23% i.e. ₹ 321cr spent in investingℹ
45.86% i.e. ₹ 299cr earned in financingℹ
0% in otherℹ
MorepenLaboratorieshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 4cr

.Itis
Downℹ
by

180

%.
45.34% i.e. ₹ 73cr earned in operatingℹ
51.55% i.e. ₹ 83cr spent in investingℹ
3.11% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
TheincomeofMorepenLaboratoriesis

₹ 416cr

and

Profit

is:

₹ 41cr

MorepenLaboratoriesProfitisupby:

272.73

%andIncomeisDownby:

3.03

%
TheincomeofMorepenLaboratoriesis

₹ 429cr

and

Profit

is:

₹ 11cr

MorepenLaboratoriesProfitisdownby:

45

%andIncomeisDownby:

8.72

%
TheincomeofMorepenLaboratoriesis

₹ 470cr

and

Profit

is:

₹ 20cr

MorepenLaboratoriesProfitisdownby:

23.08

%andIncomeisUpby:

2.62

%
By using this site you agree to the use of cookies to deliver a better site experience.